Summary
In order to evaluate the proliferation and differentiation potentials of ethylnitrosourea (ENU)-induced rat glioma cells, the authors attempted to obtain a cell line that maintains glial features in long-term culture. One of five cell lines cultivated from ENU-induced rat gliomas merited particular interest because of the differentiation of its neoplastic glia. This cell line, designated as HITS glioma, had a polygonal cell body and formed a monolayer with pile-up fociin vitro, in contrast to the other cell lines, which displayed a mesenchymal change through passages. GFAP-positive cells, found in the primary culture, disappeared in the late passages of HITS glioma, as they did in the other cell lines. Galactocerebroside (GC), GD3 ganglioside, and Leu7 were not expressed in the cell lines during culture. Subcutaneous inoculation of HITS glioma into neonatal rats induced tumors with histopathological components mimicking the histopathological appearance of ENU-induced gliomas. The components also had a fraction of GFAP-positive cells. Such findings indicate that HITS glioma cells may be composed of immature glial cells which are able to differentiate into astrocytic cells under certain conditions.
Several growth factors which play a role in gliogenesis were used to evaluate the mechanism(s) of proliferation and/or differentiation of HITS glioma. These growth factors did not induce the expression of GFAP and other antigenic expression in HITS glioma, even though some promoted the proliferation of HITS glioma. Although the mechanism involving the astrocytic differentiation of HITS glioma is unknown, HITS glioma may serve as an effective tool in research to evaluate the mechanisms of proliferation and differentiation of neoplastic glia.
Similar content being viewed by others
References
Bogler O, Wren D, Barnett SC, Land H, Noble M: Cooperation between two growth factors promotes extended selfrenewal and inhibits differentiation of oligodendrocytetype-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 87: 6368–6372, 1990
Borit A, McIntosh GC: Myelin basic protein and glial fibrillary acidic protein in human fetal brain. Neuropathol Appl Neurobiol 7: 279–287, 1981
Conley FK: The immunocytochemical localization of GFA Protein in experimental murine CNS tumors. Acta Neuropathol (Berl) 45: 9–16, 1979
Dahl D: The vimentin-GFA Protein transition in rat neuroglia cytoskeleton occurs at the time of myelination. J Neurosci Res 6: 741–748, 1981
de la Monte SM: Uniform lineage of oligodendrogliomas. Am J Pathol 135(3): 529–540, 1989
Druckrey H, Ivankovic S, Preussmann R: Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 210: 1378–1379, 1966
Dutly F, Schwab ME: Neurons and astrocytes influence the development of purified O-2A progenitor cells. Glia 4: 559–571, 1991
Gammeltoft S, Ballotti R, Kowalski A, Westermark B, Obberghan EV: Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res 48: 1233–1237, 1988
Giordana MT, Mauro A, Schiffer D: Glycosaminoglycans of brain tumors transplacentally induced by ENU in the rat. Acta Neuropathol (Berl) Suppl VII: 79–80, 1981
Giulian D, Young DG, Woodward J, Brown DC, Lachman LB: Interleukin-I is an astroglial growth factor in the developing brain. J Neurosci 8: 709–714, 1988
Gratzner HG: Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218: 474–475, 1982
Han VKM, Lauder JM, D'Ercole AJ: Characterization of Somatomedin/Insulin-like growth factor receptors and correlation with biologic action in cultured neonatal rat astroglial cells. J Neurosci 7(2): 501–511, 1987
Herpers MJHM, Budka H: Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: Gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol (Berl) 64: 265–272, 1984
Higami Y: Response of ethylnitrosourea-induced rat glioma to growth factors in primary culture. Nagasaki Med J 62(2): 150–172, 1990 (in Japanese with English abstract)
Hsu S-M, Raine L, Fanger H: Use of avidin-biotin-peroxydase complex (ABC) in immunoperoxydase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29(4): 577–580, 1981
Jagadha V, Halliday WC, Becker LE: Glial fibrillary acidic protein (GFAP) in oligodendrogliomas: A reflection of transient GFAP expression by immature oligodendroglia. Can J Neurol Sci 13: 307–311, 1986
Kiess W, Lee L, Graham DE, Greenstein L, Tseng LY-H, Rechler MM, Nissley SP: Rat C6 glial cells synthesize Insulin-like growth factor I (IGF-I) and express IGF-I receptors and IGF-II/mannose 6-phosphate receptors. Endocrinology 124: 1727–1736, 1989
Kim SU, Moretto G, Shin DH, Lee VM: Modulation of antigenic expression in cultured adult human oligodendrocytes by derivatives of adenosine 3′, 5′-cyclic monophosphate. J Neurol Sci 69: 81–91, 1985
Ko L, Koestner A, Wechsler W: Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol (Berl) 51: 23–31, 1980
Koestner A, Swenberg JA, Wechsler W: Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am J Pathol 63(1): 37–50, 1971
Le Vine SM, Goldman JE: Ultrastructural characteristics of GD3 ganglioside-positive immature glia in rat forebrain white matter. J Comp Neurol 277: 456–464, 1988
Mauro A, Giordana MT, Migheli A, Schiffer D: Glial fibrillary acidic protein (GFAP) in rat brain tumors transplacentally induced by ethylnitrosourea (ENU). J Neurol Sci 61: 349–355, 1983
McKeever PE: Functional aspects of alterations in glioma cell antigens. Neuroimmunol Res 2: 19–39, 1989
McMorris FA, Smith TM, DeSalvo S, Furlanetto RW: Insulin-like growth factor I/Somatomedin C: A potent inducer of oligodendrocyte development. Proc Natl Acad Sci USA 83: 822–826, 1986
McMorris FA, Dubois-Dalcq M: Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developingin vitro. J Neurosci Res 21: 199–209, 1988
Merrill MJ, Edwards NA: Insulin-like growth factor-I receptors in human glial tumors. J Clin Endocrinol Metab 71(1): 199–209, 1990
Nakagawa Y, Perentes E, Rubinstein LJ: Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers. Acta Neuropathol (Berl) 72: 15–22, 1986
Peatau A: Glial fibrillary acidic protein, vimentin and fibronectin in primary cultures of human glioma and fetal brain. Acta Neuropathol (Berl) 75: 448–455, 1988
Raff MC, Rhona M, Fields KL, Lisak RP, Dorfman SH, Silberberg DH, Gregson NA, Leibowitz S, Kennedy MC: Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature 274: 813–816, 1978
Raff MC, Miller RH, Noble M: A glial progenitor cell that developsin vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303(2): 390–396, 1983
Reifenberger G, Bilzer T, Seitz RJ, Wechsler W: Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines. Acta Neuropathol (Berl) 78: 270–282, 1989
Ross R, Raines EW, Bowen-Pope DF: The biology of platelet-derived growth factor. Cell 46: 155–169, 1986
Sandberg A-C, Engberg C, Lake M, von Holst H, Sara VR: The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci Lett 93: 114–119, 1988
Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Green MI, Weinberg RA: The neu oncogene: an erbB-related gene encoding a 185, 000-Mr tumour antigen. Nature 312: 513–516, 1984
Shapiro JR: Biology of gliomas: Heterogeneity, oncogenes, growth factors. Semin Oncol 13(1): 4–15, 1986
Shemer J, Raizada MK, Masters BA, Ota A, LeRoith D: Insulin-like growth factor I receptors in neuronal and glial cells. J Biol Chem 262(16): 7693–7699, 1987
Shimokawa I: Immunohistochemical properties of glial cells of ethylnitrosourea induced brain tumor in the rat. Acta Med Nagasaki 31: 90–116, 1986
Sternberger NH, Itoyama Y, Kies MW, Webster HF: Myelin basic protein demonstrated immunocytochemically in oligodendroglioma prior to myelin sheath formation. Proc Natl Acad Sci USA 75(5): 2521–2524, 1978
Takesima F, Iwasaki K, Shimokawa I, Ikeda T, Matsuo T: Immunohistochemical localization of gangliosides in ENU-induced rat glioma. Acta pathol Jpn 42(8): 558–565, 1992
Yoshimine T, Maruno M, Ushio Y, Hayakawa T, Nakajima Y, Mogami H: Intermediate filaments and anaplastic change of ENU-induced gliomas: immunohistochemical study with vimentin and astroprotein (GFAP). J Neurooncol 5: 377–385, 1987
Yoshino T, Motoi M, Ogawa K: Morphological maturation of tumor cells induced by ethylnitrosourea (ENU) in rat brains. I. On the tumors by administration of ENU in the late gestational stage. Acta Pathol Jpn 35(6): 1385–1396, 1985
Zapf J, Froesch ER, Humbel RE: The Insulin-like growth factors (IGF) of human serum: Chemical and biological characterization and aspects of their possible physiological role. Curr Top Cell Regul 19: 257–309, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ikeno, Y., Shimokawa, I., Higami, Y. et al. GFAP expression in the subcutaneous tumors of immature glial cell line (HITS glioma) derived from ENU-induced rat glioma. J Neuro-Oncol 17, 191–204 (1993). https://doi.org/10.1007/BF01049975
Issue Date:
DOI: https://doi.org/10.1007/BF01049975